153 related articles for article (PubMed ID: 29290748)
1. Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.
Cies JJ; LaCoursiere RJ; Moore WS; Chopra A
J Pediatr Pharmacol Ther; 2017; 22(6):467-470. PubMed ID: 29290748
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J
Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
Sumitani Y; Kobayashi Y
Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209
[TBL] [Abstract][Full Text] [Related]
5. How and why aztreonam works.
Rittenbury MS
Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
[TBL] [Abstract][Full Text] [Related]
6. Effects of i.v. push administration on β-lactam pharmacodynamics.
Butterfield-Cowper JM; Burgner K
Am J Health Syst Pharm; 2017 May; 74(9):e170-e175. PubMed ID: 28438821
[TBL] [Abstract][Full Text] [Related]
7. Steady-State Ceftazidime-Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration.
Soukup P; Faust AC; Edpuganti V; Putnam WC; McKinnell JA
Pharmacotherapy; 2019 Dec; 39(12):1216-1222. PubMed ID: 31596506
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
9. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacodynamics of Prolonged Infusion β-Lactams for the Treatment of Pseudomonas aeruginosa Infections: A Systematic Review.
Thabit AK; Hobbs ALV; Guzman OE; Shea KM
Clin Ther; 2019 Nov; 41(11):2397-2415.e8. PubMed ID: 31679822
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of aztreonam in children with cystic fibrosis.
Reed MD; Aronoff SC; Stern RC; Yamashita TS; Myers CM; Friedhoff LT; Blumer JL
Pediatr Pulmonol; 1986; 2(5):282-6. PubMed ID: 3774385
[TBL] [Abstract][Full Text] [Related]
14. [Treatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged vs. regular infusion].
Lü Y; Yan Z; Wang DH; Dong WL; Yang Y; Xia R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):479-83. PubMed ID: 24021044
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
Shea KM; Cheatham SC; Smith DW; Wack MF; Sowinski KM; Kays MB
Ann Pharmacother; 2009 Nov; 43(11):1747-54. PubMed ID: 19809009
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1985 Mar; 15(3):375-84. PubMed ID: 3922936
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam lysine for inhalation: new formulation of an old antibiotic.
Zeitler K; Salvas B; Stevens V; Brown J
Am J Health Syst Pharm; 2012 Jan; 69(2):107-15. PubMed ID: 22215356
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.
Pilmis B; Petitjean G; Lesprit P; Lafaurie M; El Helali N; Le Monnier A;
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1457-1461. PubMed ID: 31073653
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of Levoffoxacin in an Obese Adolescent: A Case Report.
Hanretty AM; Moore WS; Chopra A; Cies JJ
J Pediatr Pharmacol Ther; 2020; 25(3):261-265. PubMed ID: 32265612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
